Procter & Gamble (PG) Given New $80.00 Price Target at Morgan Stanley

Procter & Gamble (NYSE:PG) had its price target reduced by Morgan Stanley from $85.00 to $80.00 in a research note released on Friday. They currently have an equal weight rating on the stock.

Several other analysts also recently weighed in on the stock. Zacks Investment Research upgraded shares of Procter & Gamble from a hold rating to a buy rating and set a $102.00 price objective for the company in a research report on Monday, January 8th. Goldman Sachs upgraded shares of Procter & Gamble from a sell rating to a neutral rating and set a $77.00 price objective for the company in a research report on Tuesday, January 16th. JPMorgan Chase boosted their price objective on shares of Procter & Gamble from $90.00 to $98.00 and gave the stock a neutral rating in a research report on Wednesday, January 24th. Stifel Nicolaus boosted their price objective on shares of Procter & Gamble from $87.00 to $88.00 and gave the stock a hold rating in a research report on Wednesday, January 24th. Finally, SunTrust Banks restated a hold rating and set a $90.00 price objective on shares of Procter & Gamble in a research report on Tuesday, January 23rd. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of Hold and a consensus price target of $84.13.

Procter & Gamble stock traded down $1.15 during trading on Friday, reaching $73.80. The stock had a trading volume of 14,078,880 shares, compared to its average volume of 9,161,566. Procter & Gamble has a 52-week low of $73.74 and a 52-week high of $94.67. The company has a quick ratio of 0.79, a current ratio of 0.94 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $188,949.23, a P/E ratio of 18.83, a P/E/G ratio of 2.37 and a beta of 0.57.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Thursday, April 19th. The company reported $1.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. Procter & Gamble had a net margin of 15.17% and a return on equity of 20.82%. The company had revenue of $16.28 billion during the quarter, compared to the consensus estimate of $16.22 billion. During the same quarter in the previous year, the firm earned $0.96 earnings per share. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. research analysts anticipate that Procter & Gamble will post 4.2 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th will be issued a $0.7172 dividend. This represents a $2.87 dividend on an annualized basis and a dividend yield of 3.89%. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.69. The ex-dividend date is Thursday, April 19th. Procter & Gamble’s payout ratio is presently 73.21%.

In other news, insider Marylynn Fergusonmchugh sold 2,353 shares of Procter & Gamble stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $78.59, for a total value of $184,922.27. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Vice Chairman Jon R. Moeller sold 3,252 shares of Procter & Gamble stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $78.59, for a total transaction of $255,574.68. The disclosure for this sale can be found here. Insiders sold a total of 114,011 shares of company stock worth $9,710,976 over the last ninety days. Corporate insiders own 0.35% of the company’s stock.

Several institutional investors have recently made changes to their positions in PG. Signature Estate & Investment Advisors LLC acquired a new position in Procter & Gamble in the 4th quarter valued at $103,000. Earnest Partners LLC acquired a new position in Procter & Gamble in the 4th quarter valued at $110,000. Cerebellum GP LLC acquired a new position in Procter & Gamble in the 4th quarter valued at $122,000. Harding Loevner LP acquired a new position in Procter & Gamble in the 2nd quarter valued at $119,000. Finally, Kohmann Bosshard Financial Services LLC acquired a new position in Procter & Gamble in the 3rd quarter valued at $125,000. 60.95% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: This story was posted by WKRB News and is the sole property of of WKRB News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The legal version of this story can be read at https://www.wkrb13.com/2018/04/21/procter-gamble-pg-given-new-80-00-price-target-at-morgan-stanley.html.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods to consumers in the United States, Canada, Puerto Rico, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company's Beauty segment offers hair care products, including conditioners, shampoos, styling aids, and treatments; and skin and personal care products, such as antiperspirant and deodorant, personal cleansing, and skin care products.

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply